255 related articles for article (PubMed ID: 10367935)
1. Does "death receptor" signaling play a role in tumorigenesis and cancer therapy?
Villunger A; Strasser A
Oncol Res; 1998; 10(11-12):541-50. PubMed ID: 10367935
[TBL] [Abstract][Full Text] [Related]
2. Messengers of cell death: apoptotic signaling in health and disease.
Rossi D; Gaidano G
Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
[TBL] [Abstract][Full Text] [Related]
3. The Bcl-2 protein family and its role in the development of neoplastic disease.
Heiser D; Labi V; Erlacher M; Villunger A
Exp Gerontol; 2004 Aug; 39(8):1125-35. PubMed ID: 15288687
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
[TBL] [Abstract][Full Text] [Related]
5. Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria.
Denecker G; Vercammen D; Steemans M; Vanden Berghe T; Brouckaert G; Van Loo G; Zhivotovsky B; Fiers W; Grooten J; Declercq W; Vandenabeele P
Cell Death Differ; 2001 Aug; 8(8):829-40. PubMed ID: 11526436
[TBL] [Abstract][Full Text] [Related]
6. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
[TBL] [Abstract][Full Text] [Related]
7. Physician Education: Apoptosis.
Kataoka S; Tsuruo T
Oncologist; 1996; 1(6):399-401. PubMed ID: 10388021
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways.
Yin XM
Cell Res; 2000 Sep; 10(3):161-7. PubMed ID: 11032168
[TBL] [Abstract][Full Text] [Related]
9. Zinc inhibits Bax and Bak activation and cytochrome c release induced by chemical inducers of apoptosis but not by death-receptor-initiated pathways.
Ganju N; Eastman A
Cell Death Differ; 2003 Jun; 10(6):652-61. PubMed ID: 12761574
[TBL] [Abstract][Full Text] [Related]
10. Mouse models of cell death.
Ranger AM; Malynn BA; Korsmeyer SJ
Nat Genet; 2001 Jun; 28(2):113-8. PubMed ID: 11381252
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
Totzke G; Schulze-Osthoff K; Jänicke RU
Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
[TBL] [Abstract][Full Text] [Related]
13. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
14. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.
Maddika S; Booy EP; Johar D; Gibson SB; Ghavami S; Los M
J Cell Sci; 2005 Oct; 118(Pt 19):4485-93. PubMed ID: 16179607
[TBL] [Abstract][Full Text] [Related]
15. LIGHT sensitizes IFN-gamma-mediated apoptosis of HT-29 human carcinoma cells through both death receptor and mitochondria pathways.
Zhang MC; Liu HP; Demchik LL; Zhai YF; Yang DJ
Cell Res; 2004 Apr; 14(2):117-24. PubMed ID: 15115612
[TBL] [Abstract][Full Text] [Related]
16. [Death inducing ligands in combination with ionizing radiation: objective and current knowledge].
Belka C; Betsch A; Marini P; Jendrossek V; Bamberg M; Budach W
Strahlenther Onkol; 2003 Mar; 179(3):141-51. PubMed ID: 12627256
[TBL] [Abstract][Full Text] [Related]
17. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice.
Eichhorst ST; Krueger A; Müerköster S; Fas SC; Golks A; Gruetzner U; Schubert L; Opelz C; Bilzer M; Gerbes AL; Krammer PH
Nat Med; 2004 Jun; 10(6):602-9. PubMed ID: 15146177
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis signaling in tumor therapy.
Fulda S; Debatin KM
Ann N Y Acad Sci; 2004 Dec; 1028():150-6. PubMed ID: 15650241
[TBL] [Abstract][Full Text] [Related]
19. Overcoming resistance of cancer cells to apoptosis.
Hersey P; Zhang XD
J Cell Physiol; 2003 Jul; 196(1):9-18. PubMed ID: 12767037
[TBL] [Abstract][Full Text] [Related]
20. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
